REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea
· Delayed Price · Currency is KRW 10,920
-90 (-0.82%)
At close: Apr 16, 2025, 3:30 PM KST
REYON Pharmaceutical Revenue
In the year 2024, REYON Pharmaceutical had annual revenue of 148.30B KRW, down -1.83%. REYON Pharmaceutical had revenue of 37.31B in the quarter ending December 31, 2024, a decrease of -3.97%.
Revenue
148.30B
Revenue Growth
-1.83%
P/S Ratio
1.39
Revenue / Employee
331.03M
Employees
448
Market Cap
205.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 148.30B | -2.77B | -1.83% |
| Dec 31, 2023 | 151.07B | -2.97B | -1.93% |
| Dec 31, 2022 | 154.04B | 11.24B | 7.87% |
| Dec 31, 2021 | 142.80B | 12.77B | 9.82% |
| Dec 31, 2020 | 130.03B | -1.52B | -1.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| LigaChem Biosciences | 125.90B |
| Peptron | 3.15B |